All In Biotech

Drug Trial Radar · NCT07734311

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Ecnoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Aug 3, 2026

Primary completion

May 31, 2028

Study completion Jun 30, 2028

Sponsor

Sponsor type
Industry
First posted
Jul 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of the study is to evaluate the efficacy and safety of ecnoglutide injections versus placebo in obese participants with KOA.

Conditions

  • Knee Osteoarthritis
  • Obesity

Interventions

  • Ecnoglutide InjectionDrug

    subcutaneous injection

  • placebo with matching volumeDrug

    subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale ScoreTime frame: Baseline, week 68
  2. Percentage Change in Body WeightTime frame: Baseline, week 68

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.